Get startedLog in
    Picture of Zealand Pharma A/S logo

    ZEAL — Zealand Pharma A/S Income Statement

    0.000.00%
    dk flag iconLast trade - 00:00
    HealthcareSpeculativeLarge CapContrarian
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Zealand Pharma A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.

    R2020
    December 31st
    R2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSInterim ReportARSARSARS
    Standards:
    IFRS    		—
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue19210910434362.7
    Cost of Revenue
    Gross Profit19297.610432454.8
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses8188931,0641,0511,335
    Operating Profit-626-784-960-708-1,272
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-674-759-972-709-1,083
    Provision for Income Taxes
    Net Income After Taxes-669-755-966-704-1,079
    Net Income Before Extraordinary Items
    Extraordinary Items
    Net Income-847-1,018-1,202-704-1,079
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-847-1,018-1,202-704-1,079
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-17.4-17.6-18.3-10.8-16.2
    Dividends per Share